Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: How low the bar?

JAMA

Volumn 298, Issue 4, 2007, Pages 452-454

  Nishimura, Rick A ^a,b   Ommen, Steve R ^a  

^a MAYO CLINIC   (United States)

^b Gonda 05 368   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATOR; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SUDDEN DEATH; SURVIVAL; SYMPTOMATOLOGY; SYNCOPE; TRICUSPID VALVE REGURGITATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; NOTE;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 34547228308     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10):1308-1320.
2. Nishimura RA, Holmes DR Jr. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350(13):1320-1327.
3. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80(6):739-744.
4. McKenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy, I: influence on prognosis. Br Heart J. 1981;46(2):168-172.
5. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort [published correction appears in JAMA. 1999;281(24):2288]. JAMA. 1999;281(7):650-655.
6. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986;7(1):204-214.
7. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342(6):365-373.
8. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36(7):2212-2218.
9. Maron BJ, McKenna W, Danielson GK, et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol. 2003;42(9):1687-1713.
10. Maron BJ, Spirito P, Shen W-K, et al. Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298(4):405-412.
11. Elliott PM, Gimeno B Jr, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357(9254):420-424.
12. Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM III, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45(10):1672-1675.
13. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342(24):1778-1785.
14. Sorajja P, Nishimura RA, Ommen SR, Ackerman MJ, Tajik AJ, Gersh BJ. Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. J Am Soc Echocardiogr. 2006;19(6):788-795.
15. Sorajja P, Ommen SR, Nishimura RA, McCully RB, Tajik AJ, Gersh BJ. The long-term outcome of patients with hypertrophic cardiomyopathy and coronary artery disease. J Am Coll Cardiol. 2003;41(6)(suppl A):169A.
16. Elliott P, Gimeno J, Tome M, McKenna W. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Eur Heart J. 2006;27(24):3073.
17. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112(6):855-861.